GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment.
Saved in:
| Title: | GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment. |
|---|---|
| Authors: | Williams CH; Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI, USA.; Henry Ford Health + Michigan State Health Sciences, Detroit, MI, USA., Neitzel LR; Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI, USA.; Henry Ford Health + Michigan State Health Sciences, Detroit, MI, USA., Cornell J; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Rea S; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Mills I; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA., Silver MS; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Ahmad JD; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Birukov KG; Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD, USA., Birukova A; Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA., Brem H; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Tyler B; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Bar EE; Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, USA.; Department of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, USA.; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Hong CC; Department of Medicine, Michigan State University College of Human Medicine, East Lansing, MI, USA. hongchar@msu.edu.; Henry Ford Health + Michigan State Health Sciences, Detroit, MI, USA. hongchar@msu.edu. |
| Source: | Experimental hematology & oncology [Exp Hematol Oncol] 2024 Jan 31; Vol. 13 (1), pp. 13. Date of Electronic Publication: 2024 Jan 31. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101590676 Publication Model: Electronic Cited Medium: Print ISSN: 2162-3619 (Print) Linking ISSN: 21623619 NLM ISO Abbreviation: Exp Hematol Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
